Hypertriglyceridemia may be severe in CML patients treated with interferon‐α
- 11 July 1995
- journal article
- Published by Wiley in American Journal of Hematology
- Vol. 49 (3) , 240-241
- https://doi.org/10.1002/ajh.2830490311
Abstract
We analyzed serum triglyceride (TG) levels in 22 chronic myeloid leukemia (CML) patients treated with interferon‐α (IFN‐α). Hypertriglyceridemia was present in one‐half of patients at diagnosis, and IFN‐α treatment was associated with a further increase in 90% of the total group of patients. This increase was maximal during the first months of therapy. Four patients (18%) reached levels higher than 1,000 mg/dl. This is the first report describing this secondary effect in CML patients treated with IFN‐α.Keywords
This publication has 10 references indexed in Scilit:
- Alpha-Interferon and Reversible HypertriglyceridemiaAnnals of Internal Medicine, 1993
- Role of Interleukin-1 Inhibitory Molecules in Therapy of Acute and Chronic Myelogenous LeukemiaLeukemia & Lymphoma, 1993
- Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndromeThe American Journal of Medicine, 1991
- Evidence for Two Classes of Cytokines That Stimulate Hepatic Lipogenesis: Relationships among Tumor Necrosis Factor, Interleukin-1 and Interferon-Alpha*Endocrinology, 1990
- Changes in serum lipids in patients with condylomata acuminata treated with interferon alfa-nl (Wellferon)Journal of the American Academy of Dermatology, 1988
- Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients.The Journal of Experimental Medicine, 1986
- Hypocholesterolemia as a manifestation of disease activity in chronic myelocytic leukemiaCancer, 1983
- Plasma lipid alterations in leukemia and lymphomaThe American Journal of Medicine, 1982